Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Hirakawa, Mami"" wg kryterium: Autor


Wyświetlanie 1-11 z 11
Tytuł:
Rationale and design of a multicenter, double-blinded, randomized, placebo-controlled trial to investigate the effects of naldemedine on opioid-induced constipation for patients with cancer pain: A study protocol
Autorzy:
Higashibata, Takahiro
Hamano, Jun
Kessoku, Takaomi
Kajiura, Shinya
Hirakawa, Mami
Horie, Yoshiki
Shimizu, Masaki
Oyamada, Shunsuke
Ariyoshi, Keisuke
Kihara, Kota
Yamanaka, Yohei
Konishi, Kumi
Doki, Kosuke
Takashima, Yasuyuki
Horiuchi, Manabu
Homma, Masato
Yamada, Takeshi
Yamamoto, Yoshiyuki
Moriwaki, Toshikazu
Morita, Tatsuya
Nakajima, Atsushi
Nagaoka, Hiroka
Pokaż więcej
Źródło:
In Contemporary Clinical Trials Communications October 2022 29
Czasopismo naukowe
Tytuł:
Loureirin C and Xanthoceraside Prevent Abnormal Behaviors Associated with Downregulation of Brain Derived Neurotrophic Factor and AKT/mTOR/CREB Signaling in the Prefrontal Cortex Induced by Chronic Corticosterone Exposure in Mice
Autorzy:
Yang, YangAff1, Aff2
Mouri, AkihiroAff1, Aff5, IDs1106402203694x_cor2
Lu, QiaohuiAff1, Aff2
Kunisawa, Kazuo
Kubota, Hisayoshi
Hasegawa, Masaya
Hirakawa, Mami
Mori, Yuko
Libo, Zou
Saito, KuniakiAff3, Aff5
Nabeshima, ToshitakaAff4, Aff5
Pokaż więcej
Źródło:
Neurochemical Research. 47(9):2865-2879
Czasopismo naukowe
Tytuł:
Phase I study of the anti-heparin-binding epidermal growth factor-like growth factor antibody U3-1565 with cetuximab in patients with cetuximab- or panitumumab-resistant metastatic colorectal cancer
Autorzy:
Nakajima, Takako Eguchi
Boku, Narikazu
Doi, Ayako
Arai, Hiroyuki
Mizukami, Takuro
Horie, Yoshiki
Izawa, Naoki
Hirakawa, Mami
Ogura, Takashi
Tsuda, Takashi
Sunakawa, Yu
Pokaż więcej
Źródło:
Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies. 38(2):410-418
Czasopismo naukowe
Tytuł:
Infusion site adverse events in breast cancer patients receiving highly emetic chemotherapy with prophylactic anti-emetic treatment with aprepitant and fosaprepitant: A retrospective comparison.
Autorzy:
Tsuda T; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan.
Kyomori C; Department of Nursing, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan.
Mizukami T; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan.
Taniyama T; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan.
Izawa N; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan.
Horie Y; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan.
Hirakawa M; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan.
Ogura T; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan.
Nakajima TE; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan.
Tsugawa K; Division of Breast and Endocrine Surgery, Department of Surgery, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan.
Boku N; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan.
Pokaż więcej
Źródło:
Molecular and clinical oncology [Mol Clin Oncol] 2016 Apr; Vol. 4 (4), pp. 603-606. Date of Electronic Publication: 2016 Feb 05.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Predictability of antitumor efficacy of cetuximab plus irinotecan based on skin rash severity according to observation period in patients with metastatic colorectal cancer following failure of fluorouracil, irinotecan and oxaliplatin.
Autorzy:
Horie Y; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Kanagawa 216-8511, Japan ; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Shizuoka 411-8777, Japan.
Yamazaki K; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Shizuoka 411-8777, Japan.
Funakoshi T; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Shizuoka 411-8777, Japan.
Hamauchi S; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Shizuoka 411-8777, Japan.
Taniguchi H; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Shizuoka 411-8777, Japan.
Tsushima T; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Shizuoka 411-8777, Japan.
Todaka A; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Shizuoka 411-8777, Japan.
Machida N; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Shizuoka 411-8777, Japan.
Taku K; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Shizuoka 411-8777, Japan.
Fukutomi A; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Shizuoka 411-8777, Japan.
Onozawa Y; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Shizuoka 411-8777, Japan.
Yasui H; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Shizuoka 411-8777, Japan.
Mizukami T; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Kanagawa 216-8511, Japan.
Izawa N; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Kanagawa 216-8511, Japan.
Hirakawa M; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Kanagawa 216-8511, Japan.
Tsuda T; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Kanagawa 216-8511, Japan.
Nakajima T; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Kanagawa 216-8511, Japan.
Boku N; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Kanagawa 216-8511, Japan.
Pokaż więcej
Źródło:
Molecular and clinical oncology [Mol Clin Oncol] 2015 Sep; Vol. 3 (5), pp. 1029-1034. Date of Electronic Publication: 2015 Jun 24.
Typ publikacji:
Journal Article
Czasopismo naukowe
    Wyświetlanie 1-11 z 11

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies